PURPOSE: The Department of Health and Senior Services has prepared a list of all drugs falling within the purview of controlled substances.

PUBLISHER’S NOTE: The secretary of state has determined that publication of the entire text of the material that is incorporated by reference as a portion of this rule would be unduly cumbersome or expensive. This material as incorporated by reference in this rule shall be maintained by the agency at its headquarters and shall be made available to the public for inspection and copying at no more than the actual cost of reproduction. This note applies only to the reference material. The entire text of the rule is printed here.

1. (1) Schedules of Controlled Substances.

   1. (A) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) Controlled Substances Code Number set forth opposite it.

      1. 1. Opiates. Unless specifically excepted or unless listed in

another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

1. A. Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)- 4-piperidinyl)-N- phenylacetamide)
2. B. Acetylmethadol
3. C. Acetyl fentanyl (N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide)
4. D. N-(1-phenethylpiperidin- 4-yl)-N-phenylacrylamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other names: acryl fentanyl, acryloylfentanyl)
5. E. AH-7921(3,4-dichloro- N-[(1-dimethylamino) cyclohexylmethyl] benzamide)
6. F. Allylprodine
7. G. Alphacetylmethadol (except levoalphacetylmethadol also known as levo-alphaacetylmethadol levothadyl acetate or LAAM)
8. H. Alphameprodine
9. I. Alphamethadol
10. J. Alpha-methylfentanyl (N-1-(alphamethyl-betaphenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl- 2-phenylethyl)-4 ((N- propanilido) piperidine)

1. K. Alpha-methylthiofentanyl (N-(1-methyl-2-(2-thienyl) ethyl-4-piperidinyl)-N- phenylpropanamide)
2. L. Benzethidine
3. M. Betacetylmethadol
4. N. Beta-hydroxyfentanyl (N-(1-(2-hydroxy-2- phenethyl)-4-piperidinyl)- N-phenylpropanamide)
5. O. Beta-hydroxy-3- methylfentanyl (other name: N-(1-(2-hydroxy-2-phenethyl)- 3-methyl-4-piperidinyl)-N- phenylpropanamide)
6. P. N-[1-[2-hydroxy-2-(thiophen- 2-yl) ethyl]piperidin-4-yl]- N-phenylpropionamide (other names: beta-hydroxythiofentanyl)
7. Q. Betameprodine
8. R. Betamethadol
9. S. beta-Methyl fentanyl (N-phenyl-N-(1-(2- phenylpropyl)piperidin-4-yl) propionamide (Other name: β-methyl fentanyl)
10. T. beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)- N,3-diphenylpropanamide (other names: β'-phenyl fentanyl; 3-phenylpropanoyl Fentanyl)
11. U. Betaprodine
12. V. Brorphine (1-(1-(1-(4-bromophenyl) ethyl)piperidin-4-yl)-1,3-dihydro-2H- benzo[d]imidazol-2-one)
13. W. Butyryl fentanyl (N- (1-phenethylpiperidin-4-yl)- N-phenylbutyramide)
14. X. Clonitazene
15. Y. Crotonyl fentanyl ((E)-N-(1- phenethylpiperidin-4-yl)-N- phenylbut-2-enamide)
16. Z. N-(1-phenethylpiperidin- 4-yl)-N- Phenylcyclopentanecarboxamide (other name: cyclopentyl fentanyl) AA. Cyclopropyl fentanyl (N-(1- phenethylpiperidin-4-yl)-N- phenylcyclopropanecarboxamide) BB. Dextromoramide
17. CC. Diampromide
18. DD. Diethylthiambutene EE. Difenoxin FF. Dimenoxadol GG. Dimepheptanol HH. Dimethylthiambutene
19. II. Dioxaphetyl butyrate JJ. Dipipanone KK. Ethylmethylthiambutene
20. LL. Etonitazene
21. MM. Etoxeridine NN. Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl) (phenyl)carbamate) OO. N-(4-fluorophenyl)-N- (1-phenethylpiperidin-4- yl)isobutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other names: 4-fluoroisobutyryl fentanyl, parafluoroisobutyryl fentanyl) PP. 2'-Fluoro orthofluorofentanyl (N-(1-(2- fluorophenethyl) piperidin- 4-yl)-N-(2-fluorophenyl) propionamide (other names: 2'-fluoro 2-fluorofentanyl) QQ. N-(1-phenethylpiperidin- 4-yl)-N-phenylfuran-2- carboxamide (other names: furanyl fentanyl) RR. Furethidine SS. Hydroxypethidine TT. N-(1-phenethylpiperidin- 4-yl)-N-phenylisobutyramide (other name: isobutyryl fentanyl) UU. Isotonitazene (N,N-diethyl-2-(2- (4-isopropoxybenzyl)-5-nitro- 1H-benzimidazol-1-yl) ethan-1-amine)
22. VV. Ketobemidone WW. Levomoramide
23. XX. Levophenacylmorphan YY. Methoxyacetyl fentanyl (2-methoxy-N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide ZZ. 4'-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl) piperidin-4-yl)-N- phenylacetamide) AAA. 3-Methylfentanyl (N-(3- methyl-1-(2-phenylethyl)-4- piperidyl)-N- phenylproanamide), its optical and geometric isomers, salts, and salts of isomers BBB. 3-Methylthiofentanyl (N- (3-methyl-1-(2- thienyl)ethyl-4-piperidinyl)- N-phenylpropanamide)
24. CCC. Metonitazene (N,N-diethyl- 2-(2-(4-methoxybenzyl)-5-nitro-1H- benzimidazol-1-yl)ethan-1-amine)
25. DDD. Morpheridine EEE. MPPP (1-methyl-4-phenyl-4- propionoxypiperidine) FFF. MT–45 (1-cyclohexyl- 4-(1,2-diphenylethyl) piperazine) (9560) GGG. Noracymethadol HHH. Norlevorphanol
26. III. Normethadone JJJ. Norpipanone KKK. N-(2-fluorophenyl)-2-methoxy-N-(1- phenethylpiperidin-4- yl)acetamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other name: ocfentanil)
27. LLL. ortho-Fluoroacryl fentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) acrylamide)
28. MMM. ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl) butyramide (other name: 2-fluorobutyryl fentanyl) NNN. ortho-Fluorofentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) propionamide); other name: 2-fluorofentanyl) OOO. ortho-Fluoroisobutyryl fentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)isobutyramide) PPP. ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl) acetamide (other name: 2-methyl acetylfentanyl) QQQ. ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- methylphenyl)-N-(1- phenethylpiperidin-4-yl) acetamide (other name: 2-methyl methoxyacetyl fentanyl) RRR. N-(4-chlorophenyl)-N- (1-phenethylpiperidin- 4-yl)isobutyramide (other name: parachloroisobutyryl fentanyl) SSS. para-Fluorobutyryl fentanyl (N-(4- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)butyramide) TTT. para-Fluorofentanyl(N- (4-fluorophenyl)-N-(1-(2- phenethyl)-4-piperidinyl) propanamide UUU. para-Fluoro furanyl fentanyl (N-(4- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)furan-2-carboxamide)
29. VVV. para-Methoxybutyryl fentanyl (N-(4- methoxyphenyl)-N-(1- phenethylpiperidin-4-yl) butyramide) WWW. para-Methylfentanyl (N-(4-methylphenyl)-N- (1-phenethylpiperidin-4-yl) propionamide (other name: 4-methylfentanyl)
30. XXX. PEPAP (1-(-2-phenethyl)- 4-phenyl-4-acetoxypiperidine) YYY. Phenadoxone ZZZ. Phenampromide AAAA. Phenomorphan BBBB. Phenoperidine
31. CCCC. Phenyl fentanyl (N-(1- phenethylpiperidin-4-yl)- N-phenylbenzamide (other name: benzoyl fentanyl)
32. DDDD. Piritramide EEEE. Proheptazine FFFF. Properidine GGGG. Propiram HHHH. Racemoramide
33. IIII. N-(1-phenethylpiperidin-4-yl)- N-phenyltetrahydrofuran- 2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other name: tetrahydrofuranyl fentanyl) JJJJ. Thiofentany (N-phenyl- N-(1-(2-thienyl)ethyl-4- piperidinyl)-propanamide KKKK. Thiofuranyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-N-phenylthiophene- 2-carboxamide (other names: 2-thiofuranyl fentanyl; thiophene fentanyl)
34. LLLL. Tilidine
35. MMMM. Trimeperidine NNNN. U–47700 (3,4-Dichloro- N-[2-(dimethylamino) cyclohexyl]-N- methylbenzamide) OOOO. N-(1-phenethylpiperidin- 4-yl)-N-phenylpentanamide (other name: valeryl fentanyl) PPPP. Zipeprol (1-methoxy-3-[4- (2-methoxy-2-phenylethyl) piperazin-1-yl]-1-phenylpropan-2-ol)
36. 2. Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
37. A. Acetorphine
38. B. Acetyldihydrocodeine
39. C. Benzylmorphine
40. D. Codeine methylbromide
41. E. Codeine-N-Oxide

42. F. Cyprenorphine

    1. 3. Hallucinogenic substances. Unless specifically excepted

    or unless listed in another schedule, any material, compound,

9841 mixture or preparation, which contains any quantity of the 9642 following hallucinogenic substances or which contains any of 9643 its salts, isomers, and salts of isomers whenever the existence 9644 of such salts, isomers, and salts of isomers is possible within 9649 the specific chemical designation (For purposes of paragraph 9645 (1)(A)3. of this rule only, the term isomer includes the optical, position, and geometric isomers.):

Some trade or other names: etryptamine; Monase; alpha-ethyl- 1H-indole-3-ethenamine; 3-(2-aminobutyl)indole; alpha-ET; and AET;

Some trade or other names: 4-bromo-2, 5- dimethoxy-a-

9843 methylphenethylamine; 4-bromo- 2, 5-DMA;

9835 Some amethylphenethylamine; 2,5-DMA;

Some trade or other names: DOET;

9051 Some trade or other names: 4-methoxy-amethylphenethylamine; 9052 paramethoxyamphetamine; PMA; G. Desomorphine H. Dihydromorphine I. Drotebanol J. Etorphine (except hydrochloride salt) K. Heroin L. Hydromorphinol M. Methyldesorphine N. Methyldihydromorphine O. Morphine methylbromide P. Morphine methylsulfonate Q. Morphine-N-Oxide R. Myrophine S. Nicocodeine T. Nicomorphine U. Normorphine V. Pholcodine W. Thebacon

1. A. Alpha-ethyltryptamine
2. B. 4-bromo-2,5-dimethoxyamphetamine
3. C. 4-bromo-2,5-dimethoxyphenethylamine
4. D. 2,5-dimethoxyamphetamine trade or other names: 2,5-dimethoxy-
5. E. 2,5-dimethoxy-4-ethylamphetamine
6. F. 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)
7. G. 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)
8. H. 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)
9. I. 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)
10. J. 2-(2,5-Dimethoxy-4-nitrophenyl) ethanamine (2C-N)
11. K. 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)
12. L. 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)
13. M. 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2)
14. N. 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)
15. O. 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4)
16. P. 4-methoxyamphetamine
17. Q. 5-methoxy-3,4- methylenedioxyamphetamine

18. R. 4-methyl-2,5-dimethoxyamphetamine Some trade and other names: 4-methyl-2, 5- dimethoxy-amethylphenethylamine; DOM; and STP;

    1. S. 3,4-methylenedioxyamphetamine
    2. T. 3,4-methylenedioxymethamphetamine(MDMA)
    3. U. 3,4-methylenedioxy-N- ethylamphetamine (also known as N-ethylalphamethyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA)
    4. V. N-hydroxy-3,4- methylenedioxyamphetamine (also known as N-hydroxyalpha-methyl-3,4 (methylenedioxy) phenethylamine and N- hydroxy MDA)
    5. W. 3,4,5-trimethoxyamphetamine
    6. X. 5-MeO-DMT or 5-methoxy- N,N-dimethyltryptamine
    7. Y. Alpha-methyltryptamine
    8. Z. Bufotenine

Some trade and other names: 3-(b-Dimethylaminoethyl)- 5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine; AA. Diethyltryptamine Some trade and other names: N, N-Diethyltryptamine; DET; BB. Dimethyltryptamine Some trade or other names: DMT;

1. CC. 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeODIPT)
2. DD. Ibogaine

Some trade and other names: 7-Ethyl- 6,6β,7,8,9,10,12,13- octahydro-2-methoxy-6, 9-methano-5H-pyrido azepino[5,4-b] indole; Tabernanthe iboga; EE. Lysergic acid diethylamide FF. Marihuana Some trade or other names: marijuana; GG. Mescaline HH. Parahexyl Some trade or other names: 3-Hexyl-1- hydroxy-7,8,9,10- tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran; Synhexyl;

1. II. Peyote

Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds, or extracts; JJ. N-ethyl-3-piperidyl benzilate KK. N-methyl-3-piperidyl benzilate

1. LL. Psilocybin
2. MM. Psilocyn NN. Tetrahydrocannabinols naturally contained

a plant of the genus Cannabis (cannabis 7370 plant), as well as synthetic equivalents of the substances contained in the cannabis plant or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers, or both, with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:

1. (I) 1 cis or trans tetrahydrocannabinol and their optical

isomers;

1. (II) 6 cis or trans tetrahydrocannabinol and their optical isomers;

7400 optical isomers; and

internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered;

Some trade or other names: N-ethyl-1- phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;

Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine PCPy, PHP;

Some trade or other names: 1-(1-(2-thienyl)- cyclohexyl)- piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP;

Some other names: TCPy;

N,

[1’,2’:1,2]

in

1. (III) 3,4 cis or trans tetrahydrocannabinol and its
2. (IV) Since nomenclature of these substances is not

OO. Ethylamine analog of phencyclidine 7455

ethylamine, N-(1-phenylcyclohexyl)-

PP. Pyrrolidine analog of phencyclidine 7458

QQ. Thiophene analog of phencyclidine 7470

RR. 1-(1-(2-thienyl)cyclohexyl) pyrrolidine 7473

SS. Salvia divinorum TT. Salvinorin A UU. 3-Fluoromethcathinone 1233 VV. 4-Fluoromethcathinone 1238 WW. Mephedrone, or 4- methylmethcathinone 1248 XX. Methylenedioxypyrovalerone, MDPV, or (1-(1,3-Benzodioxol-5-yl)- 2-(1-pyrrolidinyl)-1- pentanone 7535 YY. Methylone, or 3,4- Methylenedioxymethcathinone 7540 ZZ. Quinolin-8-yl 1-pentyl- 1Hindole-3-carboxylate (PB-22; QUPIC) 7222 AAA. Quinolin-8-yl 1-(5- fluoropentyl)-1H-indole- 3-carboxylate (5-fluoro- PB-22; 5F-PB-22) 7225 BBB. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (4-fluorobenzyl)-1Hindazole- 3-carboxamide (AB-FUBINACA) 7012 CCC. N-(1-amino-3, 3-dimethyl-1- oxobutan-2-yl)-1-pentyl- 1H-indazole-3-carboxamide (ADB-PINACA) 7035 DDD. (1-pentyl-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone (other names: UR-144, 1-pentyl-3-(2,2,3,3- tetramethylcyclopropoyl)indole) 7144 EEE. [1-(5-fluoro-pentyl)- 1Hindol-3-yl](2,2,3,3- tetramethylcyclopropyl) methanone (other names: 5-fluoro-UR-144, 5-F-UR- 144, XLR11, 1-(5-fluoropentyl)-3-(2,2,3,3- tetramethylcyclopropoyl)indole) 7011 FFF. N-(1-adamantyl)-1-pentyl- 1Hindazole-3-carboxamide (other names: APINACA, AKB48) GGG. 2-(4-iodo-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (other names: 251-NBOMe; 2C-I- NBOMe; 25I; Cimbi-5) HHH. 2-(4-chloro-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (other names: 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) III. 2-(4-bromo-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (other names: 25B- NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) JJJ. 4-methyl-N-ethylcathinone (other names: 4-MEC; 2- (ethylamino)-1-(4- methylphenyl)propan-1-one) KKK. 4-methyl-alphapyrrolidinopropiophenone, (other names: 4-MePPP; MePPP; 4-methyl- α-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2- (pyrrolidin-1-yl)-propan-1-one) LLL. alphapyrrolidinopentiophenone (other names: α-PVP; α- pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one) 7545 MMM. Butylone (other names: bk-MBDB; 1-(1,3- benzodioxol-5-yl)-2- (methylamino)butan-1-one) NNN. Pentedrone (other names: α- methylaminovalerophenone; 2-(methylamino)-1-phenylpentan-1-one) 1246 OOO. Pentylone (other names: bk-MBDP; 1-(1,3- benzodioxol-5-yl)-2- (methylamino)pentan-1-one) PPP. Naphyrone (other names: naphthylpyrovalerone; 1- (naphthalen-2-yl)-2- (pyrrolidin-1-yl)pentan-1-one) QQQ. alpha-pyrrolidinobutiophenone (other names: α-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one) 7546 RRR. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole-3-carboxamide (other names: AB-CHMINACA) SSS. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-pentyl- 1Hindazole-3-carboxamide (other names: AB-PINACA) TTT. [1-(5-fluoropentyl)- 1H-indazol-3-yl](naphthalen- 1-yl)methanone (other names: THJ-2201) 7024 UUU. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole-3-carboxamide (other names: MAB- CHMINACA; ADB-CHMINACA) 7032 VVV. methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)-3,3- dimethylbutanoate (other names: 5F–ADB; 5F–MDMB–PINACA) 7034 WWW. methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)-3- methylbutanoate (other names: 5F–AMB) 7033 XXX. N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole- 3-carboxamide (other names: 5F–APINACA, 5F– AKB48) 7049 YYY. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole- 3-carboxamide (other names: ADB–FUBINACA) 7010 ZZZ. methyl 2-(1-(cyclohexylmethyl)- 1H-indole-3-carboxamido)-3,3- dimethylbutanoate (other names: MDMB–CHMICA, MMB–CHMINACA) 7042 AAAA. methyl 2-(1-(4-fluorobenzyl)- 1H-indazole-3-carboxamido)-3,3- dimethylbutanoate (other names: MDMB–FUBINACA) 7020 BBBB. methyl 2-(1-(4-fluorobenzyl)-1H- indazole-3-carboxamido)-3- methylbutanoate (other names: FUB–AMB, MMB– FUBINACA, AMB–FUBINACA) (7021) CCCC. 1-(1,3-benzodioxol- 5-yl)-2-(ethylamino) propan-1-one (ethylone) 7547 DDDD. Naphthalen-1-yl 1- (5-fluoropentyl)-1H- indole-3-carboxylate (other names: NM2201; CBL2201) 7221 EEEE. N-(1-amino-3-methyl- 1-oxobutan-2-yl)-1- (5-fluoropentyl)-1H- indazole-3-carboxamide (other name: 5F-AB-PINACA) 7025 FFFF. 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide (other names: 4-CN- CUMYLBUTINACA; 4-cyano-CUMYL- BUTINACA; 4-CN- CUMYLBINACA; CUMYL-4CNBINACA; SGT-78) 7089 GGGG. methyl 2-(1-(cyclohexylmethyl)-1H- indole-3-carboxamido)-3- methylbutanoate (other names: MMB- CHMICA; AMB-CHMICA) HHHH. 1-(5-fluoropentyl)-N- (2-phenylpropan-2-yl)- 1H-pyrrolo[2,3-b] pyridine-3-carboxamide (other name: 5F-CUMYL-P7AICA) IIII. N-ethylpentylone (other names: ephylone, 1-(1,3- benzodioxol-5-yl)-2- (ethylamino)-pentan-1-one) JJJJ. methyl 2-(1-(4-fluorobutyl)- 1H-indazole-3-carboxamido)-3, 3-dimethylbutanoate (4F–MDMB–BINACA, 4F–MDMB–BUTINACA) KKKK. 1-(4-methoxyphenyl)-N- methylpropan-2-amine (other names: paramethoxymethamphetamine, PMMA) LLLL. ethyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)-3,3- dimethylbutanoate (other name: 5F-EDMB-PINACA) MMMM. methyl 2-(1-(5-fluoropentyl)- 1H-indole-3-carboxamido)-3,3- Dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201) NNNN. N-(adamantan-1-yl)-1-(4- fluorobenzyl)-1H-indazole-3- carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)) OOOO. 1-(5-fluoropentyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) PPPP. (1-(4-fluorobenzyl)-1H- indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (other name: FUB-144) QQQQ. N-Ethylhexedrone (other names: α-ethylaminohexanophenone; 2- (ethylamino)-1-phenylhexan-1-one) RRRR. alpha-Pyrrolidinohexanophenone (other names: α-PHP; α- pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1- one) SSSS. 4-Methyl-alpha-ethylaminopentiophenone (other names: 4-MEAP; 2-(ethylamino)-1- (4-methylphenyl)pentan-1-one) TTTT. 4'-Methyl-alpha-pyrrolidinohexiophenone (other names: MPHP; 4'-methylalpha-pyrrolidinohexanophenone; 1- (4-methylphenyl)-2-(pyrrolidin-1-yl)hexan- 1-one) UUUU. alpha-Pyrrolidinoheptaphenone (other names: PV8; 1-phenyl-2- (pyrrolidin-1-yl)heptan-1-one)

1. VVVV. 4'-Chloro-alpha-pyrrolidinovalerophenone

WWWW. 2-(ethylamino)-2-

1. XXXX. 1-(1,3-benzodioxol-5-yl)-2-9

YYYY. Synthetic

exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. (I) Any compound

3-(1-naphthoyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Including, but not limited to:

1. (II) Any compound

3-(1-naphthoyl)pyrrole by atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

1. (III) Any compound

1-(1-naphthylmethyl)indene 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)

7548 methyl or 2-(4-morpholinyl)ethyl group, whether or not further (other names: 4-chloro-α-PVP; 4'-chloro-α- pyrrolidinopentiophenone; 1-(4- chlorophenyl)-2-(pyrrolidin-1-yl) pentan- 1-one)

(3-methoxyphenyl)cyclohexan- 1-one (methoxetamine, MXE)

(ethylamino)butan-1-one (other names: eutylone; bk-EBDB) cannabinoids: Unless specifically

structurally derived

or 1Hindol-3-yl-(1-naphthyl)methane

2-(4-morpholinyl)ethyl

1. (a) AM2201, or 1-(5-fluoropentyl)-3- (1-naphthoyl)indole
2. (b) JWH-007, or 1-pentyl-2-methyl- 3-(1-naphthoyl)indole
3. (c) JWH-015, or 1-propyl-2-methyl-3-(1- naphthoyl)indole
4. (d) JWH-018, or 1-pentyl- 3-(1-naphthoyl)indole
5. (e) JWH-019, or 1-hexyl- 3-(1-naphthoyl)indole
6. (f) JWH-073, or 1-butyl- 3-(1-naphthoyl)indole
7. (g) JWH-081, or 1-pentyl-3-(4-methoxy-1- naphthoyl)indole
8. (h) JWH-098, or 1-pentyl-2-methyl-3-(4- methoxy-1-naphthoyl)indole
9. (i) JWH-122, or 1-pentyl-3-(4-methyl-1- naphthoyl)indole
10. (j) JWH-164, or 1-pentyl-3-(7-methoxy-1- naphthoyl)indole
11. (k) JWH-200, or 1-(2-(4-(morpholinyl)ethyl))- 3-(1-naphthoyl)indole
12. (l) JWH-210, or 1-pentyl-3-(4-ethyl-1- naphthoyl)indole

13. (m) JWH-398, or 1-pentyl-3-(4-chloro-1- naphthoyl)indole structurally derived substitution at the nitrogen

    structurally derived

    by substitution

    from

    from

    from

at the substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;

1. (IV) Any compound structurally derived

3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Including, but not limited to:

1. (a) JWH-201, or 1-pentyl-3-(4- methoxyphenylacetyl)indole
2. (b) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole
3. (c) JWH-250, or 1-pentyl- 3-(2-methoxypheny-lacetyl)indole
4. (d) JWH-251, or 1-pentyl-3-(2- methylphenylacetyl)indole
5. (e) RCS-8, or 1-(2-cyclohexylethyl)-3-(2- methoxypheny-lacetyl)indole
6. (V) Any compound structurally derived

2-(3-hydroxycyclohexyl)phenol by substitution 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to:

1. (a) CP 47,497 and homologues, or 2-[(1R,3S)-3-

hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol), where side chain n=5, and homologues where side chain n-4, 6, or 7 7297, 7298

1. (VI) Any compound containing a 3- (benzoyl)indole

structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl 2-(4-morpholinyl)ethyl group, whether or not substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to:

1. (a) AM-694, or 1-(5-fluoropentyl)-3-(2- iodobenzoyl)indole
2. (b) RCS-4, or 1-pentyl-3-(4- methoxybenzoyl)indole (SR-19 and RCS-4)
3. (VII) CP 50,556-1, or [(6S,6aR,9R,10aR)-9-hydroxy-6-

methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10aoctahydrophenanthridin- 1-yl] acetate; (VIII) HU-210, or (6aR,10aR)-9-(hydroxymethyl)-6,6- dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol;

1. (IX) HU-211, or Dexanabinol,(6aS,10aS)-9-

(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

1. (X) Dimethylheptylpyran, or DMHP.
2. 4. Depressants. Unless specifically excepted or unless

listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Gamma-hydroxybutyric acid and other names GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutonic acid; sodium oxybate; sodium oxybutryrate from 5. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

   Some trade or other names: aminoxaphen; 2-amino-5-phenyl- 2-oxazoline; 4,5-dihydro-5-phenyl-2-oxazolamine;

from

at the

Some trade or other names: 2-(methylamino)-propiophenone;

or alpha-(methylamino)

further phenylpropan-1-one; monomethylpropion; methylcathinine; AL-464; AL-422; AL-463 and URI 432;

(some other names: N,N-alpha-trimethylbenzeneethanamine; N,N-alpha-trimethylphenethylamine)

1. 6. A temporary listing of substances subject to emergency

scheduling under federal law shall include any material, compound, mixture, or preparation which contains any quantity of the following substances:

not otherwise listed under another Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act 21 U.S.C. 355, that is structurally related to fentanyl by one (1) or more of the following modifications:

1. B. Mecloqualone
2. C. Methaqualone
3. A. Amineptine (7-[(10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5-yl)amino] heptanoic acid)
4. B. Aminorex
5. C. N-benzylpiperazine (some other names: BZP, 1- benzylpiperzaine)
6. D. Cathinone (Some trade or other names: 2-amino-1- phenyl-1-propanone, alphaaminopropiophenone, 2-aminopropiophenone and norephedrone)
7. E. 4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-dihydro-4- methyl-5-(4-methylphenyl)-2- oxazolamine; 4-methyl-5-(4- methylphenyl)-4,5-dihydro- 1,3-oxazol-2-amine)
8. F. Fenethylline
9. G. Mesocarb (N-phenyl-N′-(3- (1-phenylpropan-2-yl)-1,2,3-oxadiazol- 3-ium-5-yl)carbamimidate)

10. H. Methcathinone

    propiophenone; 2-(methylamino)-1- alpha-N-methylaminopropiophenone; ephedrone; N-methylcathinone;

11. I. Methiopropamine (N-methyl-1- (thiophen-2-yl)propan-2-amine)
12. J. 4-methoxymethcathinone
13. K. cis-4-methylaminorex (cis-4,5-dihydro-4-methyl- 5-phenyl-2-oxazolamine)
14. L. 4-Methyl-alphapyrrolidinobutiophenone, or MPBP
15. M. N-ethylamphetamine
16. N. N,N-dimethylamphetamine

17. A. Fentanyl-related substances, their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers.

    1. (I) Fentanyl-related substance means any substance

       1. (a) Replacement of the phenyl portion of the

phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

1. (b) Substitution in or on the phenethyl group with

alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups;

1. (c) Substitution in or on the piperidine ring with

alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups;

1. (d) Replacement of the aniline ring with any

aromatic monocycle whether or not further substituted in or on the aromatic monocycle; and/or

1. (e) Replacement of the N-propionyl group by

another acyl group.

1. B. 2-(2-(4-butoxybenzyl)-5-nitro-1H- benzimidazol-1-yl)-N, N-diethylethan-1- amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Butonitazene)
2. C. 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)- N, N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other names: Etodesnitazene; etazene)
3. D. N, N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro- 1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Flunitazene)
4. E. N,N-diethyl-2-(2-(4-methoxybenzyl)-1H- benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Metodesnitazene)
5. F. 2-(4-ethoxybenzyl)-5-nitro-1- (2-(pyrrolidin-1-yl)ethyl) -1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other names: N-pyrrolidino etonitazene; etonitazepyne)
6. G. N, N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)- 1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Protonitazene)
7. H. 4-(2-chlorophenyl)-2-ethyl-9- methyl-6H-thieno[3,2-f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: etizolam)
8. I. 8-chloro-6-(2-fluorophenyl)-1- methyl-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: flualprazolam)
9. J. 6-(2-chlorophenyl)-1-methyl-8- nitro-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: clonazolam)

10. K. 8-bromo-6-(2-fluorophenyl)-1- methyl-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: flubromazolam)

    1. L. 7-chloro-5-(2-chlorophenyl)-1-
    2. 7. Khat, to include all parts of the plant presently classified

    botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seed, or extracts.

    1. (B) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.

       1. 1. Substances, vegetable origin, or chemical synthesis.

    Unless specifically excepted or unless listed in another schedule, Schedule II shall include any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:

    1. A. Opium and opiate; and any salt, compound,

    derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone and their respective salts, but including the following:

    1. B. Any salt, compound, derivative, or preparation

    thereof which is chemically equivalent or identical with any of the substances referred to in subparagraph (1)(B)1.A. of this rule shall be included in Schedule II, except that these substances shall not include the isoquinoline alkaloids of opium;

    1. C. Opium poppy and poppy straw
    2. D. Coca leaves (9040) and any salt, compound, derivative,

    or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include—

    leaves, which extractions do not contain cocaine or ecgonine; or

    1. E. Concentrate of poppy straw (the crude extract

    of poppy straw in either liquid, solid, or powder form

2788 which contains the phenanthrene alkaloids of the opium methyl-1,3-dihydro-2Hbenzo [e][1,4]diazepin-2-one, its salts, isomers, and salts of isomers (Other name: diclazepam)

1. (I) Raw opium
2. (II) Opium extracts
3. (III) Opium fluid
4. (IV) Powdered opium
5. (V) Granulated opium
6. (VI) Tincture of opium
7. (VII) Codeine (VIII) Dihydroetorphine
8. (IX) Ethylmorphine
9. (X) Etorphine hydrochloride
10. (XI) Hydrocodone
11. (XII) Hydromorphone (XIII) Metopon
12. (XIV) Morphine
13. (XV) Oripavine
14. (XVI) Oxycodone (XVII) Oxymorphone (XVIII) Thebaine
15. (I) Decocainized coca leaves or extraction of coca

16. (II) Ioflupane; poppy)

    1. 2. Opiates. Unless specifically excepted or unless in

another schedule any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan, and levopropoxyphene excepted:

1. A. Alfentanil
2. B. Alphaprodine
3. C. Anileridine
4. D. Bezitramide
5. E. Bulk Dextropropoxyphene (Non-dosage Forms)
6. F. Carfentanil
7. G. Dihydrocodeine
8. H. Diphenoxylate
9. I. Fentanyl
10. J. Isomethadone
11. K. Levo-alphacetylmethadol

Some other names: levo-alphaacetylmethadol, levomethadyl acetate, LAAM

1. L. Levomethorphan
2. M. Levorphanol
3. N. Metazocine
4. O. Methadone
5. P. Methadone-Intermediate, 4-cyano-2-dimethylamino- 4,4-diphenyl butane
6. Q. Moramide-Intermediate, 2- methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid
7. R. Oliceridine (N-[(3-methoxythiophen-2-yl) methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate)
8. S. Pethidine (Meperidine)
9. T. Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine
10. U. Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate
11. V. Pethidine-Intermediate-C, 1- methyl-4-phenylpiperidine- 4-carboxylic acid
12. W. Phenazocine
13. X. Piminodine
14. Y. Racemethorphan
15. Z. Racemorphan AA. Remifentanil BB. Sufentanil
16. CC. Tapentadol
17. DD. Thiafentanil
18. 3. Stimulants. Unless specifically excepted or unless listed

in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

1. A. Amphetamine, its salts, optical isomers, and salts of its optical isomers
2. B. Lisdexamfetamine, its salts, isomers, and salts of its isomers
3. C. Methamphetamine, its salts, isomers, and salts of its isomers
4. D. Phenmetrazine and its salts
5. E. Methylphenidate
6. 4. Depressants. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

9800 5. Hallucinogenic substances:

9273 Another name for nabilone: (±)trans-3-(1, 1- dimethylheptyl)-6, 6a,7,8,10,10a-hexahydrodibenzo(b,d) pyran-9-one.

an oral solution in a drug product approved for marketing by

9226 the United States Food and Drug Administration.

1. 6. Immediate precursors. Unless specifically excepted or

unless listed in another schedule, any material, compound,

9648 mixture, or preparation which contains any quantity of the 9210 following substances:

9240 methamphetamine:

Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;

9232 7. Any material, compound, mixture, or preparation which contains any quantity of the following alkyl nitrites:

1. (C) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

9733 1. Stimulants. Unless specifically excepted or unless listed 9739 in another schedule, any material, compound, mixture, or 9740 preparation which contains any quantity of the following 9780 substances having a stimulant effect on the central nervous 9729 system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 21 CFR 308.32 and any other drug of the quantitive

1205 composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled 1105 substances A. Amobarbital B. Glutethimide C. Pentobarbital D. Phencyclidine E. Secobarbital

1. A. Nabilone

   1-hydroxy-6, 6-dimethyl-9H-

2. B. Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in

3. A. Immediate precursor to amphetamine

   1. (I) Phenylacetone

4. B. Immediate precursors to phencyclidine (PCP):

   1. (I) 1-phenylcyclohexylamine
   2. (II) 1-piperidinocyclohexanecarbonitrile (PCC)

5. C. Immediate precursor to fentanyl:

   1. (I) 4-anilino-N-phenethyl-4- piperidine (ANPP)
   2. (II) N-phenyl-N-(piperidin- 4-yl)propionamide (norfentanyl)
6. A. Amyl nitrite;
7. B. Butyl nitrite.
8. A. Those compounds, mixtures, or preparations in
9. B. Benzphetamine
10. C. Chlorphentermine
11. D. Clortermine

12. E. Phendimetrazine (7365)

    and

    1. 2. Depressants. Unless specifically excepted or unless

listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

1. A. Any compound, mixture, or preparation containing—

   1. (I) Amobarbital
   2. (II) Secobarbital
   3. (III) Pentobarbital

or any salt thereof and one (1) or more other active medicinal ingredients which are not listed in any schedule;

1. B. Any suppository dosage form containing—

   1. (I) Amobarbital
   2. (II) Secobarbital
   3. (III) Pentobarbital

or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;

1. C. Any substance which contains any quantity of a

derivative of barbituric acid or any salt thereof

1. D. Chlorhexadol
2. E. Embutramide
3. F. Any drug product containing gamma hydroxybutyric

acid, including its salts, isomers, and salts of isomer, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act;

1. G. Ketamine, its salts, isomer, and salts of isomers (some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)- cyclohexanone)
2. H. Lysergic acid
3. I. Lysergic acid amide
4. J. Methyprylon
5. K. Perampanel, and its salts, isomers, and salts of isomers
6. L. Sulfondiethylmethane
7. M. Sulfonethylmethane
8. N. Sulfonmethane
9. O. Tiletamine and zolazepam or any salt thereof

Some trade or other names for a tiletaminezolazepam combination product: Telazol. Some trade or other names for tiletamine: 2- (ethylamino)-2-(2- thienyl)-cyclohexanone. Some trade or other names for zolazepam: 4-(2-fluorophenyl)- 6-8-dihydro-1,3,8- trimethylpyrazolo-(3,4-e) (1,4)-diazepin- 7(1H)- one, flupyrazapon.

1. 3. Nalorphine
2. 4. Narcotics drugs. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

1. A. Not more than one and eight tenths grams (1.8gm)

of codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium

1. B. Not more than one and eight tenths grams (1.8gm) of

codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

1. C. Not more than one and eight tenths grams (1.8gm)

of dihydrocodeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

of ethylmorphine per one hundred milliliters (100 mL) or not more than fifteen milligrams (15 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

2316 opium per one hundred milliliters (100 mL) or per one hundred 2271 grams (100 gm) or not more than twenty-five milligrams (25 mg) per dosage unit, with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts

2126 per one hundred milliliters (100 mL) or per one hundred grams (100 gm), with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

1. 5. Any material, compound, mixture, or preparation

containing any of the following narcotic drugs or their salts, as set forth below:

2510 6. Anabolic steroids. Unless specifically excepted or 2020 unless listed in another schedule, any substance meeting the definition of anabolic steroid as set forth in 21 CFR 1300.01, of the August 1, 2023, Code of Federal Regulations, as published by the Office of the Federal Register, National Archives and Records 2012 Administration, 700 Pennsylvania Avenue, Washington, DC 20408, which is hereby incorporated by reference and does not include later amendments or additions, including any material, compound, mixture or preparation containing any quantity of the following substances, including its salts, esters, 7300 and ethers (4000):

3-one);

9400 en-3-one);

dione;

hydroxy-17α-methyl-androst-1,4-dien-3-one);

en-17β-ol) (a.k.a. “madol”);

(17β-hydroxy-5α-androst-1-en-3-one);

3-one);

1. D. Not more than three hundred milligrams (300 mg)
2. E. Not more than five hundred milligrams (500 mg) of
3. F. Not more than fifty milligrams (50 mg) of morphine
4. A. Buprenorphine 9064
5. A. 5α-androstan-3,17-dione;
6. B. 5α-androstan-3,6,17-trione;
7. C. 1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene);
8. D. 1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene);
9. E. 4-androstenediol (3β,17β-dihydroxy-androst-4-ene);
10. F. 5-androstenediol (3β,17β-dihydroxy-androst-5-ene);
11. G. 1-androstenedione (5α-androst-1-en-3,17-dione);
12. H. 4-androstenedione (androst-4-en-3,17-dione);
13. I. 5-androstenedione (androst-5-en-3,17-dione);
14. J. bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-en-
15. K. boldenone (17β-hydroxyandrost-1,4-diene-3-one);
16. L. boldione (androsta-1,4-diene-3,17-dione);
17. M. 6-bromo-androsta-1,4-diene-3,17-dione;
18. N. 6-bromo-androstan-3,17-dione;
19. O. calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-
20. P. 4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol;
21. Q. 4-chloro-17α-methyl-androst-4-ene-3β,17β-diol;
22. R. 4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one; S. 4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-
23. T. clostebol (4-chloro-17β-hydroxy-androst-4-en-3-one);
24. U. dehydrochloromethyltestosterone (4-chloro-17β-
25. V. desoxymethyltestosterone (17α-methyl-5α-androst-2-
26. W. 4-dihydrotestosterone (17β-hydroxy-androstan-3-one);
27. X. Δ1-dihydrotestosterone (a.k.a. “1-testosterone”)
28. Y. 3β,17β-dihydroxy-5α-androstane;

29. Z. 3α,17β-dihydroxy-5α-androstane; AA. 2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one; BB. drostanolone (17β-hydroxy-2α-methyl-5α-androstan-

    1. CC. 2α,3α-epithio-17α-methyl-5α-androstan-17β-ol;
    2. DD. estra-4,9,11-triene-3,17-dione; EE. 13β-ethyl-17β-hydroxygon-4-en-3-one; FF. ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene); GG. fluoxymesterone (9-fluoro-17α-methyl-11β,17β-dihy-

droxyandrost-4-en-3-one); HH. formebolone (2-formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one);

1. II. furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]

furazan); JJ. [3,2-c]furazan-5α-androstan-17β-ol; KK. 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;

1. LL. 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-

en-3-one);

1. MM. 4-hydroxy-androst-4-ene-3,17-dione; NN. 17β-hydroxy-androstano[2,3-d]isoxazole; OO. 17β-hydroxy-androstano[3,2-c]isoxazole; PP. 3β-hydroxy-estra-4,9,11-trien-17-one; QQ. 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-

en-3-one); RR. mestanolone (17α-methyl-17β-hydroxy-5α-androstan- 3-one); SS. mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3- one); TT. methandienone (17α-methyl-17β-hydroxyandrost-1,4- dien-3-one); UU. methandriol (17α-methyl-3β,17β-dihydroxyandrost-5- ene);

1. VV. methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-

3-one or 2α,17α-dimethyl-17β-hydroxy-5α-androstan-3-one); WW. methenolone (1-methyl-17β-hydroxy-5α-androst-1- en-3-one);

1. XX. 17α-methyl-androsta-1,4-diene-3,17β-diol; YY. 17α-methyl-5α-androstan-17β-ol; ZZ. 17α-methyl-androstan-3-hydroxyimine-17β-ol; AAA. 6α-methyl-androst-4-ene-3,17-dione; BBB. 17α-methyl-androst-2-ene-3,17β-diol;
2. CCC. 17α-methyl-3β,17β-dihydroxy-5α-androstane;
3. DDD. 17α-methyl-3α,17β-dihydroxy-5α-androstane; EEE. 17α-methyl-3β,17β-dihydroxyandrost-4-ene; FFF. 17α-methyl-4-hydroxynandrolone (17α-methyl-4-

hydroxy-17β-hydroxyestr-4-en-3-one); GGG. methyldienolone (17α-methyl-17β-hydroxyestra- 4,9(10)-dien-3-one); HHH. 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy- 17α-methyl-5α-androst-1-en-3-one) (a.k.a. “17-α-methyl-1-testosterone”);

1. III. methyltestosterone (17α-methyl-17β-hydroxyandrost-

4-en-3-one); JJJ. methyltrienolone (17α-methyl-17β-hydroxyestra- 4,9,11-trien-3-one); KKK. mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en- 3-one);

1. LLL. nandrolone (17β-hydroxyestr-4-en-3-one);
2. MMM. 19-nor-4-androstenediol (3β,17β-dihydroxyestr-4-

ene); NNN. 19-nor-4-androstenediol (3α,17β-dihydroxyestr-4- ene); OOO. 19-nor-5-androstenediol (3β,17β-dihydroxyestr-5- ene); PPP. 19-nor-5-androstenediol (3α,17β-dihydroxyestr-5- ene); QQQ. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)- diene-3,17-dione); RRR. 19-nor-4-androstenedione (estr-4-en-3,17-dione); SSS. 19-nor-5-androstenedione (estr-5-en-3,17-dione); TTT. norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en- 3-one); UUU. norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one);

1. VVV. norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-

one); WWW. normethandrolone (17α-methyl-17β-hydroxyestr- 4-en-3-one);

1. XXX. oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α-an-

drostan-3-one); YYY. oxymesterone (17α-methyl-4,17β-dihydroxyandrost- 4-en-3-one); ZZZ. oxymetholone (17α-methyl-2-hydroxymethylene- 17β-hydroxy-5α-androstan-3-one); AAAA. prostanozol (17β-hydroxy-5α-androstano[3,2-c] pyrazole or [3,2-c]pyrazole-5α-androstan-17β-ol); BBBB. [3,2-c]pyrazole-androst-4-en-17β-ol;

1. CCCC. stanozolol (17α-methyl-17β-hydroxy-5α-androst-2-

eno[3,2-c]-pyrazole);

1. DDDD. stenbolone (17β-hydroxy-2-methyl-5α-androst-1-

en-3-one); EEEE. testolactone (13-hydroxy-3-oxo-13,17-secoandrosta- 1,4-dien-17-oic acid lactone); FFFF. testosterone (17β-hydroxyandrost-4-en-3-one); GGGG. tetrahydrogestrinone (13β,17α-diethyl-17β-hydroxygon-4,9,11-trien-3-one); and HHHH. trenbolone (17β-hydroxyestr-4,9,11-trien-3-one).

1. 7. Dronabinol (synthetic) in sesame oil and encapsulated

in a soft gelatin capsule in a United States Food and Drug Administration approved drug product 7369 (Some other names for dronabinol: (6αRtrans)- 6a,7,8,10α- tetrahydro-6.6.9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1- ol, or (-) -delta-9-(trans)-tetrahydrocannabinol.)

1. (D) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

   1. 1. Narcotic drugs. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

1. A. Not more than one milligram (1 mg) of difenoxin (DEA

Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit 9167

1. B. Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-

diphenyl-3-methyl-2-propionoxybutane) 9278

1. C. 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)

cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol) 9752

1. D. Narcotic drugs containing nonnarcotic active

medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

1. (I) Not more than two hundred milligrams (200 mg)

of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. (II) Not more than one hundred milligrams (100 mg) of

dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm); or

1. (III) Not more than one hundred milligrams (100 mg)

of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm).

1. 2. Depressants. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Alfaxalone
2. B. Alprazolam
3. C. Barbital
4. D. Brexanolone
5. E. Bromazepam
6. F. Camazepam
7. G. Carisoprodol
8. H. Chloral betaine
9. I. Chloral hydrate
10. J. Chlordiazepoxide
11. K. Clobazam
12. L. Clonazepam
13. M. Clorazepate
14. N. Clotiazepam
15. O. Cloxazolam
16. P. Daridorexant
17. Q. Delorazepam
18. R. Diazepam
19. S. Dichloralphenazone
20. T. Estazolam
21. U. Ethchlorvynol
22. V. Ethinamate
23. W. Ethyl loflazepate
24. X. Fludiazepam
25. Y. Flunitrazepam
26. Z. Flurazepam AA. Fospropofol BB. Halazepam
27. CC. Haloxazolam
28. DD. Ketazolam EE. Lemborexant FF. Loprazolam GG. Lorazepam HH. Lormetazepam
29. II. Mebutamate JJ. Medazepam KK. Meprobamate
30. LL. Methohexital
31. MM. Methylphenobarbital (Mephobarbital) NN. Midazolam OO. Nimetazepam PP. Nitrazepam QQ. Nordiazepam RR. Oxazepam SS. Oxazolam TT. Paraldehyde UU. Petrichloral
32. VV. Phenobarbital WW. Pinazepam
33. XX. Prazepam YY. Quazepam ZZ. Remimazolam AAA. Suvorexant BBB. Temazepam
34. CCC. Tetrazepam

35. DDD. Triazolam EEE. Zaleplon

    1. 3. Lorcaserin. Any material, compound, mixture, or

    preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

2731 4. Stimulants. Unless specifically excepted or unless listed 2882 in another schedule, any material, compound, mixture, or 2145 preparation which contains any quantity of the following 2400 substances having a stimulant effect on the central nervous 2748 system, including its salts, isomers, and salts of isomers:

2758 5. Other substances. Unless specifically excepted or unless 2759 listed in another schedule, any material, compound, mixture, 2763 or preparation which contains any quantity of the following 2767 substances, including its salts:

1. 6. Ephedrine. Any material, compound, mixture, or

preparation which contains any quantity of the following substances having a stimulant effect on the central nervous

2264 system including their salts, isomers, and salts of isomers:

2884 optical isomers as the only active medicinal ingredient or 2837 contains ephedrine or its salts, optical isomers, or salts of 2834 optical isomers and therapeutically insignificant quantities of 2838 another active medicinal ingredient. 2835 (E) Schedule V shall consist of the drugs and other substances, 2839 by whatever official name, common or usual name, chemical 2585 name, or brand name designated, listed in this subsection.

1. 1. Narcotic drugs containing nonnarcotic active medicinal

ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as

2881 follows, which shall include one (1) or more nonnarcotic active 2846 medicinal ingredients in sufficient proportion to confer upon 2223 the compound, mixture, or preparation valuable medicinal 2925 qualities other than those possessed by the narcotic drug alone:

2887 of codeine per one hundred milliliters (100 mL) or per one 2781 hundred grams (100 gm); FFF. Zolpidem GGG. Zopiclone

1. A. Lorcaserin
2. A. Cathine ((+)-norpseudoephedrine)
3. B. Diethylpropion
4. C. Fencamfamin
5. D. Fenproporex
6. E. Mazindol
7. F. Mefenorex
8. G. Modafinil
9. H. Pemoline (including organometallic complexes and chelates thereof)
10. I. Phentermine
11. J. Pipradrol
12. K. Serdexmethylphenidate
13. L. Sibutramine
14. M. Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, betaamino-, carbamate (ester))
15. N. SPA (-)-1-dimethylamino-1,2-diphenylethane 1635
16. A. Pentazocine
17. B. Butorphanol (including its optical isomers) 9720
18. C. Eluxadoline (5-[[[(2S)-2-amino-3-[4- aminocarbonyl)-2,6-dimethylphenyl]-1- oxopropyl] [(1S)-1-(4-phenyl-1 H-imidazol-2-yl) ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers
19. A. Ephedrine or its salts, optical isomers, or salts of

20. A. Not more than two hundred milligrams (200 mg)

    1. B. Not more than one hundred milligrams (100 mg) of

dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. C. Not more than one hundred milligrams (100 mg) of

ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. D. Not more than two and five-tenths milligrams (2.5 mg)

of diphenoxylate and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit;

1. E. Not more than one hundred milligrams (100 mg) of

opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm); and

1. F. Not more than five-tenths milligram (0.5 mg) of

difenoxin (DEA Drug Code No. 9168) and not less than twentyfive micrograms (25 mcg) of atropine sulfate per dosage unit.

1. 2. Stimulants. Unless specifically exempted or excluded

or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including its salts, isomers, and salts of isomers:

1. A. Pyrovalerone
2. 3. Any compound, mixture, or preparation containing any

detectable quantity of pseudoephedrine or its salts or optical isomers, or salts of optical isomers or any compound, mixture, or preparation containing any detectable quantity of ephedrine or its salts or optical isomers, or salts of optical isomers if the drug preparations are starch-based solid dose forms, if such preparations are sold over the counter without a prescription. The following drug preparations containing ephedrine and pseudoephedrine are not scheduled controlled substances:

1. A. Drug preparations in liquid form; and
2. B. Drug preparations that require a prescription in order

to be dispensed.

1. 4. Unless specifically exempted or excluded or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

1. A. Ezogabine [N-[2-amino-4(4- fluorobenzylamino)-phenyl]- carbamic acid ethyl ester]
2. B. Ganaxolone (3α-hydroxy-3β-methyl- 5α-pregnan-20-one)
3. C. Lacosamide [(R)-2-acetoamido-N-benzyl- 3-methoxy-propionamide]
4. D. Pregabalin [(S)-3-(aminomethyl)-5- methylhexanoic acid]
5. E. Brivaracetam ((25)-2-[(4R)- 2-oxo-4-propylpyrrolidin-1- yl]butanamide) (also referred to as BRV; UCB-34714; Briviact)
6. F. Lasmiditan [2,4,6-trifluoro-N-(6-(1- methylpiperidine-4-carbonyl) pyridine-2- yl-benzamide]
7. G. Cenobamate ([(1R)-1-(2- chlorophenyl)-2-(tetrazol- 2-yl)ethyl] carbamate; 2H- tetrazole-2-ethanol, alpha-(2- chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol- 2-yl)ethyl ester)

1. (2) Excluded Nonnarcotic Substances. The following nonnarcotic substances which, under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301) and section 201(g)(1) of the federal Controlled Substances Act (21 U.S.C. 811(g)(1)), may be lawfully sold over the counter without a prescription, are excluded from all schedules pursuant to section 195.015(5), RSMo. Company

Bioline Laboratories Aphena Pharma Solutions—New York, LLC Goldline Laboratories Goldline Laboratories Hawthorne Products, Inc. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parmed Pharmacy Rondex Labs Smith Kline Consumer Sterling Drug, Inc. Sterling Drug, Inc. Vicks Chemical Co. White Hall Labs

AUTHORITY: section 195.015, RSMo Supp. 2023, and section 195.195, RSMo 2016.* Material found in this rule previously filed as 19 CSR 30-1.010. Original rule filed April 14, 2000, effective Nov. 30, 2000. Amended: Filed Jan. 31, 2003, effective July 30, 2003. Amended: Filed Sept. 30, 2016, effective May 30, 2017. Emergency amendment filed Oct. 25, 2018, effective Nov. 4, 2018, expired May 2, 2019. Amended: Filed Oct. 25, 2018, effective April 30, 2019. Emergency amendment filed Oct. 30, 2020, effective Nov. 16, 2020, expired May 14, 2021. Amended: Filed Oct. 30, 2020, effective April 30, 2021. Emergency amendment filed Sept. 28, 2021, effective Oct. 13, 2021, expired April 10, 2022. Amended: Filed Sept. 28, 2021, effective March 30, 2022. Emergency amendment filed Sept. 12, 2022, effective Oct. 3, 2022, expired March 31, 2023. Amended: Filed Sept. 12, 2022, effective March 30, 2023. Emergency amendment filed Sept. 25, 2023, effective Oct. 10, 2023, expired April 6, 2024. Amended: Filed Sept. 5, 2023, effective March 30, 2024. *Original authority: 195.015, RSMo 1971, amended 1989, 2014, 2020, and 195.195, RSMo 1957, amended 1971, 1989, 1993, 2014.